Bcworldpharm Co (XKRX:200780) 3-Year EBITDA Growth Rate : 50.10% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co 3-Year EBITDA Growth Rate?

Bcworldpharm Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩183.53.

During the past 12 months, Bcworldpharm Co's average EBITDA Per Share Growth Rate was 48.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 50.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bcworldpharm Co was 57.70% per year. The lowest was -34.70% per year. And the median was 2.00% per year.

Competitive Comparison of Bcworldpharm Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bcworldpharm Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's 3-Year EBITDA Growth Rate falls into.

Bcworldpharm Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bcworldpharm Co (XKRX:200780) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bcworldpharm Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bcworldpharm Co (XKRX:200780) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR

Website

http://www.bcwp.co.kr

Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co (XKRX:200780) Headlines

No Headlines